Solomon SD, McMurray JJV, Vaduganathan M, Claggett B, Jhund PS, Desai AS, Henderson AD, Lam CSP, Pitt B, Senni M, et al. Finerenone in heart failure with mildly reduced or preserved ejection fraction. 2024. New England Journal of Medicine 391(16):1475-1485.
Jhund PS, Talebi A, Henderson AD, Claggett BL, Vaduganathan M, Desai AS, Lam CSP, Pitt B, Senni M, Shah SJ, et al. Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis. 2024. The Lancet 404(10458):1119-1131.
Kondo T, Henderson AD, Docherty KF, Jhund PS, Vaduganathan M, Solomon SD, McMurray JJV. Why Have We Not Been Able to Demonstrate Reduced Mortality in Patients With HFmrEF/HFpEF? 2024. Journal of the American College of Cardiology.
Docherty KF, Henderson AD, Jhund PS, Claggett BL, Desai AS, Mueller K, Viswanathan P, Scalise A, Lam CSP, Senni M, et al. Efficacy and Safety of Finerenone Across the Ejection Fraction Spectrum in Heart Failure with Mildly Reduced and Preserved Ejection Fraction: a Prespecified Analysis of The FINEARTS-HF Trial. 2024. Circulation.
Yang M, Henderson AD, Talebi A, Atherton JJ, Chiang CE, Chopra V, Comin-Colet J, Kosiborod MN, Saraiva JF, Claggett BL, et al. Effect of finerenone on the KCCQ in patients with HFmrEF/HFpEF: A prespecified analysis of FINEARTS-HF. 2024. Journal of the American College of Cardiology.
LSHTM
Henderson AD, Butler-Cole BFC, Tazare J, Tomlinson LA, Marks M, Jit M, Briggs A, Lin L-Y, Carlile O, Bates C, et al. Clinical coding of long COVID in primary care 2020–2023 in a cohort of 19 million adults: an OpenSAFELY analysis. 2024. EClinicalMedicine 72.
Tazare J, Henderson AD, Morley J, Blake HA, McDonald H, Williamson E, Strongman H. NHS National Data Opt-Outs: trends and potential consequences for health data research. 2024. BJGP open.
Carlile O, Briggs A, Henderson AD, Butler-Cole BFC, Tazare J, Tomlinson LA, Marks M, Jit M, Lin L-Y, Bates C, et al. Impact of long COVID on health-related quality-of-life: an OpenSAFELY population cohort study using patient-reported outcome measures (OpenPROMPT). 2024. The Lancet Regional Health–Europe 40.
Matthewman J, Mulick A, Dand N, Major-Smith D, Henderson AD, Pearce N, Denaxas S, Iskandar R, Roberts A, Cornish RP, et al. Disagreement concerning atopic dermatitis subtypes between an English prospective cohort (ALSPAC) and linked electronic health records. 2024. Clinical and Experimental Dermatology llae196.
Henderson AD, Adesanya E, Mulick A, Matthewman J, Vu N, Davies F, Smith CH, Hayes J, Mansfield KE, Langan SM. Common mental health disorders in adults with inflammatory skin conditions: nationwide population-based matched cohort studies in the UK. 2023. BMC Medicine 21(1):285.
Mansfield KE, Mathur R, Tazare J, Henderson AD, Mulick AR, Carreira H, Matthews AA, Bidulka P, Gayle A, Forbes H, et al. Indirect acute effects of the COVID-19 pandemic on physical and mental health in the UK: a population-based study. 2021. The Lancet Digital Health 3(4):e217-e230.
